Zivo Bioscience
(ZIVO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,902 | 10,803 | 10,903 | 232 | 138 |
| TOTAL | $8,960 | $10,936 | $11,062 | $458 | $168 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 30 | 36 | 42 | 191 | 52 |
| TOTAL | $30 | $36 | $42 | $191 | $52 |
| Total Assets | $8,990 | $10,972 | $11,104 | $649 | $220 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 894 | 969 | 1,158 | 6,916 | 6,740 |
| Accrued Expenses | 96 | 95 | 96 | 2,600 | 2,465 |
| TOTAL | $2,948 | $3,198 | $3,642 | $11,941 | $11,394 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 122 | 122 | 122 |
| Deferred Revenues | 1,475 | 1,681 | 2,031 | 2,001 | 1,937 |
| Other Non-Current Liabilities | 0 | 3 | 7 | 10 | 15 |
| TOTAL | $N/A | $3 | $128 | $132 | $137 |
| Total Liabilities | $2,948 | $3,201 | $3,771 | $12,073 | $11,531 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,570 | 1,570 | 1,537 | 894 | 872 |
| Common Shares | 9 | 9 | 9 | 421 | 5 |
| Retained earnings | -107,059 | -104,713 | -103,128 | -101,283 | -99,064 |
| TOTAL | $6,042 | $7,771 | $7,333 | $-11,424 | $-11,311 |
| Total Liabilities And Equity | $8,990 | $10,972 | $11,104 | $649 | $220 |